Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Alcohol First News

Alcohol First News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Alcohol First. Real-time updates on events, politics, business and more.

Clairvoyant Therapeutics: First Patient Dosed in Clairvoyant's Phase 2 Clinical Trial Exploring Psilocybin as a Treatment for Alcohol Use Disorder

November 3, 2022
VANCOUVER, BC / ACCESSWIRE / November 3, 2022 / Clairvoyant Therapeutics ("Clairvoyant"), a clinical stage biotech company focused on the development of psychedelic drug therapies for the treatment of
United Kingdom British Columbia Marlo Taylor Dustin Robinson Eugene Okorie Kostenloser Wertpapierhandel
Source: finanznachrichten.de

Clairvoyant Therapeutics: Clairvoyant's Phase 2 Psilocybin Therapy Trial for Alcohol Use Disorder Obtains Regulatory Approval and Initiates 1st Clinical Site in Finland

October 13, 2022
VANCOUVER, BC / ACCESSWIRE / October 13, 2022 / Clairvoyant Therapeutics ("Clairvoyant"), a Canadian biotech company focused on the development of psychedelic drug therapies for the treatment of addiction
United Kingdom British Columbia Marlo Taylor Kostenloser Wertpapierhandel Damian Kettlewell Company On Linkedin
Source: finanznachrichten.de

Investegate |Clairvoyant Therapeutics Announcements | Clairvoyant Therapeutics: Clairvoyant Initiates First Site for Phase 2 Psilocybin Therapy Clinical Trial for Alcohol Use Disorder

July 6, 2022
Investegate announcements from Clairvoyant Therapeutics, Clairvoyant Initiates First Site for Phase 2 Psilocybin Therapy Clinical Trial for Alcohol Use Disorder
United Kingdom British Columbia Marlo Taylor Damian Kettlewell Company On Linkedin World Health Organization
Source: investegate.co.uk

Clairvoyant Therapeutics Receives Approval in Canada to Initiate a World-leading Psilocybin Trial for Treatment of Alcohol Use Disorder

January 20, 2022
VANCOUVER, BC / ACCESSWIRE / January 20, 2022 / Clairvoyant Therapeutics, a Canadian biotech company focused on the development of psychedelic drug therapies for the treatment of addiction, is pleased
United Kingdom British Columbia Marlo Taylor Kostenloser Wertpapierhandel Mark Tyndall Damian Kettlewell
Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science